+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Procarbazine (CAS 671-16-9) Global Market Research Report 2024 - Product Thumbnail Image

Procarbazine (CAS 671-16-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Pargeverine (CAS 13479-13-5) Global Market Research Report 2024 - Product Thumbnail Image

Pargeverine (CAS 13479-13-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Pemetrexed (CAS 137281-23-3) Global Market Research Report 2024 - Product Thumbnail Image

Pemetrexed (CAS 137281-23-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Pelitinib (CAS 257933-82-7) Global Market Research Report 2024 - Product Thumbnail Image

Pelitinib (CAS 257933-82-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Oxaliplatin (CAS 61825-94-3) Global Market Research Report 2024 - Product Thumbnail Image

Oxaliplatin (CAS 61825-94-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
N-Hydroxyurea (CAS 127-07-1) Global Market Research Report 2024 - Product Thumbnail Image

N-Hydroxyurea (CAS 127-07-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Nilutamide (CAS 63612-50-0) Global Market Research Report 2024 - Product Thumbnail Image

Nilutamide (CAS 63612-50-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Nilotinib (CAS 641571-10-0) Global Market Research Report 2024 - Product Thumbnail Image

Nilotinib (CAS 641571-10-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Nalfurafine (CAS 152657-84-6) Global Market Research Report 2024 - Product Thumbnail Image

Nalfurafine (CAS 152657-84-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Nelarabine (CAS 121032-29-9) Global Market Research Report 2024 - Product Thumbnail Image

Nelarabine (CAS 121032-29-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Moclobemide (CAS 71320-77-9) Global Market Research Report 2024 - Product Thumbnail Image

Moclobemide (CAS 71320-77-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Miltefosine (CAS 58066-85-6) Global Market Research Report 2024 - Product Thumbnail Image

Miltefosine (CAS 58066-85-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more